Search results - 15 results
Policy Brief – Survivorship is cancer survivorship the poor cousin of cancer control within the EBCP?
quality of life of survivors and carers, but also puts the sustainability of the healthcare and social security systems at risk. Methods We analysed the ongoing Europe Beating Cancer Plan (EBCP) to identify ...
Global and regional estimates of genital human papillomavirus prevalence among men: a systematic review and meta-analysis.
age-specific prevalences for any HPV, high-risk (HR)- HPV, and individual HPV types were estimated using random-effects models for meta-analysis and grouped by UN Sustainable Development Goals ...
Protocol for a systematic review and meta-analysis of the diagnostic test accuracy of host and HPV DNA methylation in cervical cancer screening and management.
methylation cut-off thresholds, and accuracy in high-risk HPV positive women. Our reference standard will be histology. We will perform meta-analyses using Cochrane guidelines for diagnostic test accuracy. We ...
Papilloplex HR-HPV test has non-inferior clinical performance for detection of human papillomavirus infection: assessment using the VALGENT framework.
Cervical Dysplasia Uterine Cervical Neoplasms Abstract: AIM: The Papilloplex high-risk human papillomavirus (hrHPV) test (Genefirst, Oxford, UK) is a single tube real-time HPV test which provides multiplex ...
Might Oral Human Papillomavirus (HPV) Infection in Healthy Individuals Explain Differences in HPV-Attributable Fractions in Oropharyngeal Cancer? A Systematic Review and Meta-analysis.
significant. HPV16 prevalence was 1.0% globally, and regional differences became statistically significant. A lifetime history of >6 sex partners showed a higher risk of oral HPV infection. The age-specific ...
Validation of intra- and inter-laboratory reproducibility of the Xpert HPV assay according to the international guidelines for cervical cancer screening.
Guidelines as Topic Reproducibility of Results Sensitivity and Specificity Uterine Cervical Neoplasms Abstract: BACKGROUND Cervical cancer screening with assays detecting DNA of high-risk human papillomavirus ...
VALHUDES: A protocol for validation of human papillomavirus assays and collection devices for HPV testing on self-samples and urine samples
assays are foreseen to be evaluated: RealTime High Risk HPV assay (Abbott), cobas-4800 and-6800 (Roche), Onclarity (BD), Xpert HPV (Cepheid) and Anyplex II HPV HR (Seegene). CONCLUSION: Given empirical ...
Clinical Evaluation of INNO-LiPA HPV Genotyping II Assay Using the VALGENT Framework.
assessment, we considered it as high-risk (hr) HPV positive when at least one of the following HPV types was present: HPV16, HPV18, HPV31, HPV33, HPV35, HPV39, HPV45, HPV51, HPV52, HPV56, HPV58, HPV59, and ...
Association of Endometrial Cancer Risk With Postmenopausal Bleeding in Women: A Systematic Review and Meta-analysis.
Volume 178, Issue 9 (2018) Keywords: Biopsy Endometrial Neoplasms Female Global Health Humans Postmenopause prevalence Risk Factors Uterine Hemorrhage Abstract: IMPORTANCE: As the worldwide burden of ...
Early effects of human papillomavirus vaccination in Belgium.
participating in opportunistic cervical cancer screening. A significant reduction in the prevalence of HPV 16 [relative risk (RR)=0.61, 95% confidence interval=0.39-0.95] and a nonsignificant reduction in HPV 18 ...